Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes

Por Forastiere, Arlene A., Weber, Randal S., Trotti, Andy
Publicado no J Clin Oncol (2015)

Implications of the Oropharyngeal Cancer Epidemic

Por Mroz, Edmund A., Forastiere, Arlene A., Rocco, James W.
Publicado em 2011

Comparison of Clinical and Pathological Staging in Head and Neck Squamous Cell Carcinoma: Results From Intergroup Study ECOG 4393/RTOG 9614

Por Koch, Wayne M., Ridge, John A., Forastiere, Arlene, Manola, Judith
Publicado em 2009

HPV-associated Head and Neck Cancer: A Virus-related Cancer Epidemic – A Review of Epidemiology, Biology, Virus Detection and Issues in Management

Por Marur, Shanthi, D’Souza, Gypsyamber, Westra, William H., Forastiere, Arlene A.
Publicado no Lancet Oncol (2010)

PHASE III STUDY OF RADIATION THERAPY WITH OR WITHOUT CIS-PLATINUM IN PATIENTS WITH UNRESECTABLE SQUAMOUS OR UNDIFFERENTIATED CARCINOMA OF THE HEAD AND NECK: AN INTERGROUP TRIAL OF...

Por Quon, Harry, Leong, Traci, Haselow, Robert, Leipzig, Bruce, Cooper, Jay, Forastiere, Arlene
Publicado em 2010

A phase II trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a tria...

Por Argiris, Athanassios, Ghebremichael, Musie, Burtness, Barbara, Axelrod, Rita S., Deconti, Ronald C., Forastiere, Arlene A.
Publicado em 2011

Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region

Por Wu, Tsung-Teh, Watanabe, Toshiaki, Heitmiller, Richard, Zahurak, Marianna, Forastiere, Arlene A., Hamilton, Stanley R.
Publicado em 1998

Impact of Surgeon and Hospital Volume on Short-Term Outcomes and Cost of Oropharyngeal Cancer Surgical Care

Por Gourin, Christine G., Forastiere, Arlene A., Sanguineti, Giuseppe, Marur, Shanthi, Koch, Wayne M., Bristow, Robert E.
Publicado em 2011

Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

Por Machtay, Mitchell, Moughan, Jennifer, Trotti, Andrew, Garden, Adam S., Weber, Randal S., Cooper, Jay S., Forastiere, Arlene, Ang, K. Kian
Publicado no J Clin Oncol (2008)

Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase II trial of the Eastern Cooperative Oncology Group

Por Argiris, Athanassios, Buchanan, Ashley, Brockstein, Bruce, Kolesar, Jill, Ghebremichael, Musie, Pins, Michael, Hahn, Kristine, Axelrod, Rita, Forastiere, Arlene
Publicado em 2009

Quantitative endoscopy in the chemoprevention of Barrett’s Esophagus Trial

Por Shar, A. O., Gaudard, Marie A., Heath, Elisabeth I., Forastiere, Arlene A., Yang, Vincent W., Sontag, Stephen J.
Publicado em 2008

Modeling using baseline characteristics in a small multicenter clinical trial for Barrett’s esophagus

Por Shar, Albert O., Gaudard, Marie A., Heath, Elisabeth I., Forastiere, Arlene A., Yang, Vincent W., Sontag, Stephen J.
Publicado em 2008

Patients and Physicians Can Discuss Costs of Cancer Treatment in the Clinic

Por Kelly, Ronan J., Forde, Patrick M., Elnahal, Shereef M., Forastiere, Arlene A., Rosner, Gary L., Smith, Thomas J.
Publicado no J Oncol Pract (2015)

The Impact of Gender, Partner Status, and Race on Locoregional Failure and Overall Survival in Head and Neck Cancer Patients in Three Radiation Therapy Oncology Group (RTOG) Trials

Por Dilling, Thomas J., Bae, Kyounghwa, Paulus, Rebecca, Watkins-Bruner, Deborah, Garden, Adam S., Forastiere, Arlene, Ang, K. Kian, Movsas, Benjamin
Publicado em 2011

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

Por Argiris, Athanassios, Ghebremichael, Musie, Gilbert, Jill, Lee, Ju-Whei, Sachidanandam, Kamakshi, Kolesar, Jill M., Burtness, Barbara, Forastiere, Arlene A.
Publicado em 2013

A Novel Pharmacodynamic Approach to Assess and Predict Tumor Response to the Epidermal Growth Factor Receptor Inhibitor Gefitinib in Patients with Esophageal Cancer

Por Altiok, Soner, Mezzadra, Heather, Jagannath, Sanjay, Tsottles, Nancy, Rudek, Michelle A, Abdallah, Nadia, Berman, David, Forastiere, Arlene, Gibson, Michael K.
Publicado em 2010

A Phase I Trial of Erlotinib and Concurrent Chemoradiotherapy for Stage III and IV (M0) Squamous Cell Carcinoma of the Head and Neck

Por Gilbert, Jill, Rudek, Michelle A., Higgins, Michaela J, Zhao, Ming, Bienvenu, Sara, Tsottles, Nancy, Wahl, Richard, Forastiere, Arlene, Gillison, Maura
Publicado em 2012

Eastern Cooperative Oncology Group (E1201) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/radiotherapy (RT) or irinotecan/cisplatin/RT in esophageal ade...

Por Kleinberg, Lawrence R., Catalano, Paul, Forastiere, Arlene A., Keller, Steven M., Mitchel, Edith P., Anne, Pramila Rani, Benson, Al B.
Publicado no Int J Radiat Oncol Biol Phys (2015)

Volumetric change of human papillomavirus–related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapy

Por Sanguineti, Giuseppe, Ricchetti, Francesco, Wu, Binbin, Agrawal, Nishant, Gourin, Christine, Agbahiwe, Harold, Marur, Shanthi, Clemente, Stefania, McNutt, Todd, Forastiere, Arlene
Publicado em 2012

Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression i...

Por Gilbert, Jill, Lee, Ju Whei, Argiris, Athanassios, Haigentz, Missak, Feldman, Lawrence Eric, Jang, Minyoung, Arun, Pattatheyil, Van Waes, Carter, Forastiere, Arlene A.
Publicado em 2012